14 results
Medications Used in Congestive Heart Failure

In CHF, the heart is failing as a pump; cardiac output
Heart Failure In CHF ... CHF also causes ... therapy in chronic CHF ... #Pharmacology #CHF ... #Medications #Action
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... disease; CRT, cardiac ... ventricular hypertrophy; MCS ... #CHF #Congestive ... Algorithm #Management #Cardiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... Heart #Failure #CHF ... #pharmacology # ... pathophysiology ... #cardiology
Tachypnea - Differential Diagnosis Framework

Definitions
 • Tachypnea: Respiratory rate > 20/min, shallow breathing in adults
 •
Pneumonia • CHF ... Paradoxical vocal fold motion ... (PVFM) Cardiac ... Pulmonary embolism • Cardiac ... Post-Ictal/Grand mal
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
Preserved Ejection Fraction ... cardiovascular causes ... , aborted cardiac ... Spironolactone #HFpEF #dCHF ... #Cardiology #EBM
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Heart Failure Pathophysiology ... → Inflammation causes ... endpoint of all-cause ... iron #deficiency #CHF ... diagnosis #management #cardiology
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Vaughan Williams Classification ... Vaughan #Williams #Pharmacology ... #Classification ... #Classes #pathophysiology ... #cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Reduced Ejection Fraction ... → no signs of CXR ... Consider cardiac ... diagnosis #management #cardiology ... sCHF
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Summary Cardiac ... #Classification ... #Classes #pathophysiology ... #phases #cardiology
Digoxin Pharmacology and Pathophysiology
1) Na/K ATPase Pump - Digoxin works by directly binding to and inhibiting
Digoxin Pharmacology ... and Pathophysiology ... intracellular calcium causes ... phase O of the cardiac ... #cardiology